# Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial

Study · id `cardio:ct-nct07485075` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07485075](<https://clinicaltrials.gov/study/NCT07485075>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07485075

Browse, organ or system: Kidneys; Metabolism  
Browse, condition area: Diabetes and metabolic disease; Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 104 participants.

## Technical summary

Registry record NCT07485075. Allocation not applicable; no masking; primary purpose supportive care. Start 2026-03-20 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 104 participants (planned count; ClinicalTrials.gov record NCT07485075, source copy `cardio:ctgov-nct07485075-2026-03-20`, retrieved 2026-10-26)
- Planned start: 2026-03-20 (anticipated) (ClinicalTrials.gov record NCT07485075, source copy `cardio:ctgov-nct07485075-2026-03-20`, retrieved 2026-10-26)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07485075, source copy `cardio:ctgov-nct07485075-2026-03-20`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07485075, source copy `cardio:ctgov-nct07485075-2026-03-20`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT07485075, source copy `cardio:ctgov-nct07485075-2026-03-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07485075-2026-03-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial
- Acronym: StenoFOODApp
- Condition: Diabetes Type 2
- Condition: Kidney Disease
- Intervention (Device): StenoFood App
- Lead sponsor: Steno Diabetes Center Copenhagen
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Steno Diabetes Center Copenhagen (`cardio:org-steno-diabetes-center-copenhagen`)

## Provenance

Content hash: 5f42d06955fdac9d014f6746cd33364b7ad1efc888cec3913d99d17e717b7f76
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
